Breaking News Instant updates and real-time market news.

PZZA

Papa John's

$53.47

-0.18 (-0.34%)

17:13
07/13/18
07/13
17:13
07/13/18
17:13

Yankees suspend relationship with Papa John's

The New York Yankees announced via their Twitter account that they are suspending their relationship with Papa John's. "In response to the reprehensible remarks made by Papa John's founder and owner, the New York Yankees are suspending their relationship with the company," the Yankees account tweeted.

  • 18

    Jul

PZZA Papa John's
$53.47

-0.18 (-0.34%)

05/09/18
05/09/18
DOWNGRADE

Neutral
Papa John's downgraded to Neutral following comp miss at Longbow
As previously reported, Longbow downgraded Papa John's to Neutral from Buy following the Q1 earnings and comp miss. Analyst Alton Stump is concerned Papa John's may not have a recovery in comps in the near-term and recommends investors wait for a significant pullback and or evidence same-store-sales being to recover in the coming quarters before becoming constructive on shares.
05/09/18
05/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Crocs (CROX) downgraded to Hold from Buy at Stifel with analyst Jim Duffy saying he believes the stock has "adequately" re-rated to discount fiscal 2019 earnings power. 2. Monster Beverage (MNST) downgraded to Neutral from Overweight at JPMorgan with analyst Andrea Teixeira saying she sees a "difficult road ahead" for the company following its first quarter results. 3. Adient (ADNT) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Armintas Sinkevicius saying that recent management commentary appears to have taken the potential for strategic action involving the underperforming metals business off the table. 4. Ironwood (IRWD) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst David Lebowitz saying he believes management's target of Linzess U.S. sales exceeding $1B by 2020 could be a challenge given the recent deceleration in volume growth. 5. Papa John's (PZZA) downgraded to Neutral from Buy at Longbow with analyst Alton Stump saying he is concerned Papa John's may not have a recovery in comps in the near-term and recommends investors wait for a significant pullback and or evidence same-store-sales being to recover in the coming quarters before becoming constructive on shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/18
STFL
07/11/18
NO CHANGE
Target $50
STFL
Hold
Papa John's founder's comments 'potentially a major setback,' says Stifel
After Forbes published an article detailing an incident in which founder and chairman John Schnatter used the "N-word" on a May conference call between company executives and marketing agency Laundry Service, Stifel analyst Chris O'Cull said the comments are "potentially a major setback," for the company, which was beginning to work through the PR incident in November 2017 regarding Schnatter's comments that Papa John's sales were hurt by the NFL's handling of protests by players who knelt during the National Anthem. While the company's social media activity had returned to normal levels over the last three months, O'Cull says this incident "seems to have brought old issues back to the forefront" of consumers' minds. He is also concerned that brand sentiment will turn meaningfully negative for a sustained period of time, possibly impacting the company's relationships with local NFL teams and the MLB. O'Cull has a Hold rating and $50 price target on Papa John's and expects a modest EPS decline in 2018 due to pressure from negative SRS and investments to improve the customer experience. Long-term EPS growth is seen in the 10%-15% range rather than the historical 20%+ range due to less domestic growth potential.
07/12/18
SPHN
07/12/18
NO CHANGE
Target $70
SPHN
Overweight
'Papa' John Schnatter's resignation should help stem risks, says Stephens
Stephens analyst Will Slabaugh said the resignation of John Schnatter as Chairman of the Board at Papa John's should help stem what had likely been an elevated risk of the company losing various partnerships and sponsorship deals. He looks for the company to now direct its focus toward mitigating the bad publicity from Schnatter alleged use of a racial slur on a conference call and then addressing the multiple avenues he sees available for new opportunity. Slabaugh, who still believes in the brand's positioning and growth potential, keeps an Overweight rating and $70 price target on Papa John's shares.

TODAY'S FREE FLY STORIES

BA

Boeing

$356.01

5.2 (1.48%)

07:22
07/17/18
07/17
07:22
07/17/18
07:22
Hot Stocks
Boeing signs integrated services agreement with Blackshape »

Boeing announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

NFLX

Netflix

$400.24

4.32 (1.09%)

07:22
07/17/18
07/17
07:22
07/17/18
07:22
Recommendations
Netflix analyst commentary  »

Oppenheimer remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$400.24

4.32 (1.09%)

07:22
07/17/18
07/17
07:22
07/17/18
07:22
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INXN

Interxion

$64.05

0.77 (1.22%)

07:21
07/17/18
07/17
07:21
07/17/18
07:21
Initiation
Interxion initiated  »

Interxion resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

07:20
07/17/18
07/17
07:20
07/17/18
07:20
General news
FX Update: The Dollar remained on a softening tack »

FX Update: The Dollar…

BAESY

BAE Systems

$0.00

(0.00%)

07:19
07/17/18
07/17
07:19
07/17/18
07:19
Periodicals
BAE Systems wants international partners for UK fighter project, Reuters says »

BAE Systems wants to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INAP

Internap

$11.31

-0.63 (-5.28%)

07:19
07/17/18
07/17
07:19
07/17/18
07:19
Initiation
Internap initiated  »

Internap resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$138.45

-0.91 (-0.65%)

, MA

MasterCard

$204.05

-1.86 (-0.90%)

07:19
07/17/18
07/17
07:19
07/17/18
07:19
Recommendations
Visa, MasterCard analyst commentary  »

Visa price target raised…

V

Visa

$138.45

-0.91 (-0.65%)

MA

MasterCard

$204.05

-1.86 (-0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

FDC

First Data

$22.24

-0.06 (-0.27%)

07:19
07/17/18
07/17
07:19
07/17/18
07:19
Recommendations
First Data analyst commentary  »

First Data price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

EQIX

Equinix

07:17
07/17/18
07/17
07:17
07/17/18
07:17
Initiation
Equinix initiated  »

Equinix resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Aug

MA

MasterCard

$204.05

-1.86 (-0.90%)

07:17
07/17/18
07/17
07:17
07/17/18
07:17
Recommendations
MasterCard analyst commentary  »

MasterCard price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

AUTL

Autolus Therapeutics

$23.00

2.11 (10.10%)

07:16
07/17/18
07/17
07:16
07/17/18
07:16
Initiation
Autolus Therapeutics initiated  »

Autolus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVT

Avnet

07:15
07/17/18
07/17
07:15
07/17/18
07:15
Initiation
Avnet initiated  »

Avnet initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARW

Arrow Electronics

$77.09

-0.47 (-0.61%)

07:15
07/17/18
07/17
07:15
07/17/18
07:15
Initiation
Arrow Electronics initiated  »

Arrow Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$35.08

-4.41 (-11.17%)

, PFE

Pfizer

$37.39

-0.14 (-0.37%)

07:15
07/17/18
07/17
07:15
07/17/18
07:15
Recommendations
uniQure, Pfizer analyst commentary  »

uniQure pullback on…

QURE

uniQure

$35.08

-4.41 (-11.17%)

PFE

Pfizer

$37.39

-0.14 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

AMBA

Ambarella

$37.58

-0.32 (-0.84%)

07:14
07/17/18
07/17
07:14
07/17/18
07:14
Initiation
Ambarella initiated  »

Ambarella initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BF.B

Brown-Forman, also tag with BFA, BFB

$51.18

0.14 (0.27%)

, BFA

Brown-Forman, also tag with BF.A, BF.B

$0.00

(0.00%)

07:13
07/17/18
07/17
07:13
07/17/18
07:13
Upgrade
Brown-Forman, also tag with BFA, BFB, Brown-Forman, also tag with BF.A, BF.B, Brown-Forman, also tag with BF.A, BF.B rating change  »

Brown-Forman upgraded to…

BF.B

Brown-Forman, also tag with BFA, BFB

$51.18

0.14 (0.27%)

BFA

Brown-Forman, also tag with BF.A, BF.B

$0.00

(0.00%)

BFB

Brown-Forman, also tag with BF.A, BF.B

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$207.33

(0.00%)

07:13
07/17/18
07/17
07:13
07/17/18
07:13
Periodicals
Facebook uses 'shielded review' process for popular pages, The Guardian reports »

Leading far-right…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 25

    Jul

  • 18

    Sep

CHUY

Chuy's

07:11
07/17/18
07/17
07:11
07/17/18
07:11
Downgrade
Chuy's rating change  »

Chuy's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

DLR

Digital Realty

$115.64

-0.66 (-0.57%)

07:11
07/17/18
07/17
07:11
07/17/18
07:11
Initiation
Digital Realty initiated  »

Digital Realty resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

NFLX

Netflix

$400.24

4.32 (1.09%)

07:10
07/17/18
07/17
07:10
07/17/18
07:10
Recommendations
Netflix analyst commentary  »

Netflix valuation remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLMN

Bloomin' Brands

$20.72

-0.36 (-1.71%)

07:09
07/17/18
07/17
07:09
07/17/18
07:09
Upgrade
Bloomin' Brands rating change  »

Bloomin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

CANF

Can-Fite BioPharma

$1.23

-0.04 (-3.15%)

07:09
07/17/18
07/17
07:09
07/17/18
07:09
Hot Stocks
Can-Fite BioPharma receives patent from China, Australia for sexual dysfunction »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COR

CoreSite Realty

$112.91

-0.86 (-0.76%)

07:09
07/17/18
07/17
07:09
07/17/18
07:09
Initiation
CoreSite Realty initiated  »

CoreSite Realty resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

INNT

Innovate Biopharmaceuticals

$8.07

-15.65 (-65.98%)

07:08
07/17/18
07/17
07:08
07/17/18
07:08
Initiation
Innovate Biopharmaceuticals initiated  »

Innovate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.